The estimated Net Worth of Stanley Stern is at least $296 mil dollars as of 4 September 2013. Mr. Stern owns over 27,500 units of Ekso Bionics Inc stock worth over $295,691 and over the last 18 years he sold EKSO stock worth over $0. In addition, he makes $0 as Independent Director at Ekso Bionics Inc.
Sign up
Mr. Stern EKSO stock SEC Form 4 insiders trading
Stanley has made over 6 trades of the Ekso Bionics Inc stock since 2006, according to the Form 4 filled with the SEC. Most recently he exercised 27,500 units of EKSO stock worth $13,200 on 4 September 2013.
The largest trade he's ever made was exercising 35,000 units of Ekso Bionics Inc stock on 25 August 2006 worth over $23,450. On average, Stanley trades about 5,568 units every 117 days since 2006. As of 4 September 2013 he still owns at least 261,350 units of Ekso Bionics Inc stock.
You can see the complete history of Mr. Stern stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Stanley Stern biography
Stanley B. Stern serves as Independent Director of the Company. He currently is Managing Partner of Alnitak Capital, which he founded in 2013 to provide Board level strategic advisory services, primarily in technology related industries. Before founding Alnitak, Mr. Stern was a Managing Director at Oppenheimer & Co. from 1982 to 2000 and from 2004 to 2013, where, among other positions, he led the firm’s investment banking department and technology investment banking groups. Mr. Stern also held roles at Salomon Brothers, STI Ventures and C.E. Unterberg. Mr. Stern is currently the Chairman of the Board of Audiocodes Inc., a leader in VOIP infrastructure equipment, a member of the board of directors and Chairman of the Audit Committee of Foamix, Inc., the Chairman of the Board of Sodastream, the global leader of at home beverage makers, a Board member of Ormat Technologies, a global leader in geothermal energy and a Board member of Tigo Energy, a solar energy equipment supplier. Previously, Mr. Stern was a member of the board of directors of Given Imaging, a member of the board of directors of Fundtech Inc., and chairman of the board of directors of Tucows, Inc. Mr. Stern holds a Bachelor of Arts in Economics and Accounting from City University of New York, Queens College, and a Master of Business Administration from Harvard University. Our Board of Directors has concluded that Mr. Stern is well-qualified to serve on our Board of Directors because of his extensive business and finance experience, particularly in technology related industries, and his service as a director of a number of public companies.
How old is Stanley Stern?
Stanley Stern is 62, he's been the Independent Director of Ekso Bionics Inc since 2014. There are 3 older and 7 younger executives at Ekso Bionics Inc. The oldest executive at Ekso Bionics Holdings Inc is Steven A. Sherman, 75, who is the Exec. Chairman.
What's Stanley Stern's mailing address?
Stanley's mailing address filed with the SEC is C/O EKSO BIONICS HOLDINGS, INC., 101 GLACIER POINT, SUITE A, SAN RAFAEL, CA, 94901.
Insiders trading at Ekso Bionics Inc
Over the last 9 years, insiders at Ekso Bionics Inc have traded over $898,173 worth of Ekso Bionics Inc stock and bought 276,997 units worth $399,153 . The most active insiders traders include Theodore T Wang, Steven Sherman, eRuss Angold. On average, Ekso Bionics Inc executives and independent directors trade stock every 56 days with the average trade being worth of $25,243. The most recent stock trade was executed by Scott G. Davis on 17 August 2023, trading 37,446 units of EKSO stock currently worth $37,446.
What does Ekso Bionics Inc do?
since 2005, ekso bionics has been pioneering the field of robotic exoskeletons, or wearable robots, to augment human strength, endurance and mobility. the company’s first commercially available product called ekso has helped thousands of people living with paralysis take millions of steps not otherwise possible. by designing and creating some of the most forward-thinking and innovative solutions for people looking to augment human capabilities, ekso bionics is helping people rethink current physical limitations and achieve the remarkable. ekso bionics is headquartered in richmond, california international offices: europe/middle east/africa 29th floor one canada square canary wharf london, united kingdom +44 20 7060 3568 kunden service deutschland +49 89 55067774
What does Ekso Bionics Inc's logo look like?
Complete history of Mr. Stern stock trades at Ekso Bionics Inc e Tucows
Ekso Bionics Inc executives and stock owners
Ekso Bionics Inc executives and other stock owners filed with the SEC include:
-
Jack Peurach,
President, Chief Executive Officer, Director -
William R. Shaw,
Chief Commercial Officer -
John Glenn,
Chief Financial Officer -
Jack Peurach,
Pres, CEO & Director -
John F. Glenn,
CFO & Sec. -
Jason Jones,
Vice-President of Product Development -
Steven A. Sherman,
Exec. Chairman -
Steven Sherman,
Executive Chairman of the Board -
David Carey,
IR Contact Officer -
William Shaw,
Chief Commercial Officer -
Stanley Stern,
Independent Director -
Marilyn Hamilton,
Independent Director -
Theodore Wang,
Director -
Thomas Schreck,
Independent Director -
Charles Li,
Independent Director -
Jerome Wong,
Corp. Controller -
Foon Lim Chwee,
Pres of APAC -
Anthony Pratt,
US Director of Sales -
Rachael Anderson,
Global Director of Marketing & Strategic Growth -
Scott G. Davis,
President & COO -
Theodore T Puissance Cross ...,
-
Russ Angold,
President, Ekso Labs -
Tom Looby,
President & Chief Com. Officer -
Kecheng Li,
Director -
Russ De Lonzor,
Vice Pres., Operations -
Max Scheder Bieschin,
Chief Financial Officer -
Gregory Davault,
Vice Pres., Global Marketing -
Daniel Boren,
Director -
Amy Mc Bride Wendell,
Director -
Howard D Palefsky,
Director -
Nathan Harding,
Chief Executive Officer -
Rhonda A. Wallen,
Director -
Mary Ann Cloyd,
Director -
Corinna Lathan,
Director -
Deborah Lafer Scher,
Director -
Jerome Wong,
Chief Financial Officer